phase readout
saveNCT04562766: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
ACTIVE_NOT_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Principia Biopharma, a Sanofi Company. Phase: PHASE3. Conditions: Immune Thrombocytopenia
view source ↗
comments(0)
5-min edit window · permanent after that